RYZALFA Trademark

Trademark Overview

On Monday, April 8, 2019, a trademark application was filed for RYZALFA with the United States Patent and Trademark Office. The USPTO has given the RYZALFA trademark a serial number of 88375822. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 24, 2022. This trademark is owned by Johnson & Johnson. The RYZALFA trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
ryzalfa

General Information

Serial Number88375822
Word MarkRYZALFA
Filing DateMonday, April 8, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 24, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2019

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 24, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Monday, October 24, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 24, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 21, 2022SOU EXTENSION 5 GRANTED
Monday, March 14, 2022SOU EXTENSION 5 FILED
Monday, March 21, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 14, 2022TEAS EXTENSION RECEIVED
Wednesday, September 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 13, 2021SOU EXTENSION 4 GRANTED
Monday, September 13, 2021SOU EXTENSION 4 FILED
Monday, September 13, 2021TEAS EXTENSION RECEIVED
Friday, December 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 9, 2020SOU EXTENSION 3 GRANTED
Wednesday, December 9, 2020SOU EXTENSION 3 FILED
Wednesday, December 9, 2020TEAS EXTENSION RECEIVED
Tuesday, August 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 21, 2020SOU EXTENSION 2 GRANTED
Friday, August 21, 2020SOU EXTENSION 2 FILED
Friday, August 21, 2020TEAS EXTENSION RECEIVED
Wednesday, March 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 9, 2020SOU EXTENSION 1 GRANTED
Monday, March 9, 2020SOU EXTENSION 1 FILED
Monday, March 9, 2020TEAS EXTENSION RECEIVED
Tuesday, September 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 15, 2019ASSIGNED TO EXAMINER
Wednesday, April 24, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 11, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

ryzalfa diseases anti system metabolic oncologic ophthalmic related intestinal infectious respiratory